20900 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids
Non-Enzymatic Debriding Agent and Method of Use Thereof
#902Methods and apparatus for guiding medical care based on detected gastric function
#903CHANNEL MODULATORS
#904PEPTIDE ANTIBIOTIC COMPLEXES AND METHODS OF USE THEREOF
#905Compositions for inducing urinary voiding and defecation
#906Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#907Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#908Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#909Pharmaceutical compositions and preparations for administration to the eye
#910Sincalide Formulations
#911Peptide agonists and antagonists of TLR4 activation
#912Hemiasterlin derivatives and antibody-drug conjugates including same
#913Cyclic prosaposin peptides and uses thereof
#914Angio-3 for treatment of retinal angiogenic diseases
#915Channel modulators
#916Anticancer peptides and uses thereof
#917Methods and Compositions Useful for Treating Cancer
#918METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#919Methods of treating prostate cancer with GnRH antagonist
#920Peptide inhibitors of tight junction permeability
#921PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#922Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancers
#923TISSUE OCCLUDING AGENT
#924Method of Reducing Injury to Mammalian Cells
#925Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#926Compounds for treating cancer
#927Methods and compositions related to inhibition of viral entry
#928Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes
#929Compositions and methods comprising bone morphogenetic protein and NEMO binding peptide
#930SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#931JNK Inhibitor Molecules For Treatment Of Various Diseases
#932Agent for promoting skeletal muscle injury repair
#933INHIBITORS OF BETA-ARRESTIN-NEUROKININ 1 RECEPTOR INTERACTIONS FOR THE TREATMENT OF PAIN
#934Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#935Antibacterial compositions, methods of making and use thereof
#936Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#937METHODS INVOLVING DOWNREGULATING APOBEC3B
#938Peptide exhibiting wrinkle-improving activity and uses thereof
#939Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion
#940Hyaluronic acid containing compositions for prevention of the formation of post-surgical scars and post-surgical adhesions
#941COMBINATION THERAPY FOR CANCER
#942CONJUGATES FOR IMMUNOTHERAPY
#943APPLICATION OF SELECTIVE TNFR1 ANTAGONIST PEPTIDE SN10 IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS
#944Cytotoxin and conjugate, uses of same and preparation method therefor
#945Flounder surimi having antioxidant and antihypertensive effects and method of preparing the same
#946INHIBITION OF ALPHA5BETA1 INTEGRIN WITH ATN-161 AS A NOVEL THERAPY FOR VASCULAR DEMENTIA
#947Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#948Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#949BIODEGRADABLE MICROPARTICLES FOR SUSTAINED DELIVERY OF ANTI-ANGIOGENIC PEPTIDE
#950PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#951METHODS FOR PURIFYING PROTEINS HAVING A TUBULIN CARBOXYPEPTIDASE ACTIVITY AND PEPTIDIC BASED INHIBITORS THEREOF
#952INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION
#953Prochelators as targeted prodrugs for prostate cancer and methods of making and using same
#954Saposin-A derived peptides and uses thereof
#955Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#956Compositions comprising D-amino acid peptides and methods of production and use thereof for inhibiting autoantibodies
#957Inhibition of pulmonary fibrosis with nutlin-3a and peptides
#958Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#959POLYPEPTIDE THERAPEUTICS AND USES THEREOF
#960Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#961PEPTIDES HAVING OSTEOBLAST GROWTH-PROMOTING ACTIVITY AND USE THEREOF
#962Cell permeable cyclic peptide scaffolds
#963PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE
#964Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#965Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#966ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES
#967USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
#968Mixtures and formulations comprising an alkyl ammonium EDTA salt
#969Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#970METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN
#971Glycotargeting therapeutics
#972Therapy for subarachnoid hemorrhage and ischemia
#973AGONISTS OF GUANYLATE CYCLASE USEFUL FOR DOWNREGULATION OF PRO-INFLAMMATORY CYTOKINES
#974Peptides and uses therefor as antiviral agents
#975Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue
#976Radiotherapeutic and companion imaging agents to target MC1R
#977Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour
#978Method for treating lung cancer
#979Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#980MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
#981Peptides capable of reactivating p53 mutants
#982Peptidyl ketoamides as inhibitors of rhomboid proteases
#983Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
#984Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#985Relaxin1 derived peptides for use in immunotherapy
#986B*44 restricted peptides for use in immunotherapy against cancers and related methods
#987Oral formulations of kappa opioid receptor agonists
#988Adiponectin peptidomimetics for treating ocular disorders
#989Methods for the treatment of glaucoma and age-related macular degeneration by a peptide D-TRP-AIB
#990Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#991Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#992DPEP-1 binding compositions and methods of use
#993Agent for the Treatment of Skin Wounds or Burns
#994LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#995Synthetic bile acid compositions and methods
#996COMBINATION THERAPY FOR TREATING CANCER
#997Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
#998Inhibitors of prototypic galectin dimerization and uses thereof
#999COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING
#1000Peptides having immunomodulatory properties
#1001METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#1002MEDICAL USE OF ANTI-C MET ANTIBODY-CYTOTOXIC DRUG CONJUGATE
#1003Pharmaceutical composition for preventing and treating transplant rejection
#1004Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease
#1005Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1006THERAPEUTIC METHOD USING TOLEROGENIC PEPTIDES
#1007Methods of treating female infertility
#1008HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject
#1009Passive antibody dependent cell-mediated activation
#1010Peptides and combination of peptides for use in immunotherapy against various tumors
#1011DRUG DELIVERY DEVICE WITH REMOVABLE PODS AND RELATED PODS, METHODS AND SYSTEMS
#1012Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
#1013Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1014Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1015Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1016Liposomal compositions and methods of use
#1017Monoclonal antibodies against HER2 epitope and methods of use thereof
#1018Compositions and methods of use of interleukin-10 peptides and anti-interleukin-10 antibodies
#1019Peptides and combination of peptides for use in immunotherapy against various tumors
#1020PEPTIDE INHIBITORS OF SODIUM CHANNELS
#1021Sincalide Formulations
#1022Peptides and combination of peptides for use in immunotherapy against various tumors
#1023MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#1024METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES
#1025COMPOSITION FOR TREATING PULMONARY FIBROSIS COMPRISING ALLOFERON
#1026Peptoids and methods for attenuating inflammatory response
#1027COMPOSITION FOR ANTI-PANCREATIC CANCER AND ANTI-PANCREATIC ADJUVANT COMPRISING ALLOFERON
#1028Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment
#1029Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory
#1030Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
#1031Compositions and methods for regulating blood pressure
#1032DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#1033Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1034ORGANIC COMPOUNDS
#1035Topical formulations and methods
#1036Glycan-interacting compounds and methods of use
#1037THERAPEUTIC PRODRUGS FOR NEUROLOGIC MALADIES
#1038PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME
#1039B-1A LYMPHOCYTE AND/OR MACROPHAGE TARGETING AND ACTIVATION TO TREAT MEDICAL CONDITIONS WITH INFLAMMATORY OR AUTOIMMUNE COMPONENTS
#1040MEDICAMENT FOR TREATMENT OF LIVER CANCER
#1041Peptide inhibitors targeting the pivotal anaerobic respiration factor AniA
#1042Nucleic acid constructs and methods of using the same
#1043CAPCNA PEPTIDE THERAPEUTICS FOR CANCER
#1044Pharmaceutical Composition for Preventing or Treating Hypersensitivity Immune Disease, and Method for Producing Same
#1045THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
#1046Methods and compositions for the treatment of cancer
#1047Universal antivenom
#1048Zinc-binder based EBNA1-specific compounds
#1049Cyclic peptide epitopes and small-molecule mimics for inducing autophagy
#1050GLP-1 Secretagogue and Composition
#1051COMBINATION THERAPY WITH A6, CHEMOTHERAPEUTIC AGENTS, RADIATION THERAPY, OR A COMBINATION THEREOF FOR THE TREATMENT OF CANCER
#1052Protein Hydrogels For Treatment Of Neovascular Disease
#1053Immunostimulatory method
#1054Multi-target peptide molecules of opioid and neuropeptide FF receptor, preparation for molecules, and applications thereof
#1055Anti-5T4 antibody-drug conjugate and use thereof
#1056Conjugate of salicylic acid and peptide
#1057PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME
#1058Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the MAPK pathway
#1059HSP90 inhibitory peptide conjugate and application thereof in treating tumor
#1060Preventive or therapeutic method for inflammatory skin disease
#1061Treatment of ascites
#1062IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF
#1063Antimicrobial agents against
#1064Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#1065Compositions and methods for treating disease associated with permeability of intestinal epithelium
#1066COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ENVIRONMENTAL ENTEROPATHY
#1067Methods for ameliorating memory impairment in a memory disorder caused by neuronal cell death or Abeta aggregation using a peptide
#1068Compositions comprising peptide WKDEAGKPLVK
#1069CD2-associated protein (CD2AP) and its interactive proteins
#1070C3A receptor agonists for use against ischemic brain injury, stroke, traumatic brain injury, spinal cord injury and neurodegenerative disorders
#1071Arginine-rich polypeptide compositions and methods of using same
#1072Methods and compositions for modulating opioid withdrawal symptoms
#1073HISTATIN FOR CORNEAL WOUND HEALING AND OCULAR SURFACE DISEASE
#1074Peptidomimetic macrocycles
#1075Methods and compositions for the treatment of neuropathy and hyperalgesia
#1076Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#1077Use of peptides that block metadherin-SND1 interaction as treatment for cancer
#1078Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use
#1079GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, RENAL NEPHRONS AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR
#1080Polypeptide binding to a plurality of amyloid monomers and aggregates, and use thereof
#1081Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
#1082Antibody-drug conjugates
#1083MEDICAL PREPARATION WITH A CARRIER BASED ON HYALURONAN AND/OR DERIVATIVES THEREOF, METHOD OF PREPARATION AND USE THEREOF
#1084Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1085COMPOSITIONS COMPRISING IL-2 FUSION PROTEINS AND METHODS FOR TREATING NEOPLASIA
#1086Compositions and methods for treating cancer and persistent viral infections
#1087METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#1088HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE
#1089Composition comprising protein phosphatase 1 inhibitory peptide for treating vascular diseases
#1090METHODS FOR REDUCING OXIDATIVE DAMAGE
#1091Compositions and methods of treating melanoma
#1092COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB
#1093Use of a compound, pharmaceutical composition, and therapeutic method for the treatment or prevention of convulsions
#1094SMALL CATIONIC ANTI-BIOFILM AND IDR PEPTIDES
#1095Peptides capable of reactivating p53 mutants
#1096Tyrosine peptide cross-linked biocompatible hydrogel and method of production
#1097Stable anti-CD79B immunoconjugate formulations
#1098CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#1099COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#1100VAP polypeptide and use thereof in preparation of drug for targeted diagnosis and treatment of tumor
#1101Activation and expansion of NKG2C+ NK cells
#1102Peptides useable for treating cancer
#1103Methods for treating bone loss using sclerostin peptides
#1104Composition for controlled release of therapeutic agents
#1105TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH NEUROTROPHIC PEPTIDERGIC COMPOUND
#1106Inhibitors of valosin-containing protein and methods of use
#1107Compositions targeting the interaction domain between p27Kip1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
#1108Visceral adipose tissue macrophage-targeted gene/carrier complex for preventing or treating obesity-induced type II diabetes
#1109Peptides and combination of peptides for use in immunotherapy against various tumors
#1110Method for lowering low density lipoproteins
#1111Method of treating diseases
#1112Methods of treating Prader-Willi syndrome
#1113PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#1114MEDICAL DEVICES
#1115Stable liquid formulation of AMG 416 (etelcalcetide)
#1116Synthetic somatostatin receptor ligands
#1117Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1118Prelyophilized, lyophilized and reconstituted formulations comprising TAT-NR2B9C with d-amino acids, histidine and trehalose
#1119Cyclic Peptides As C5a Receptor Antagonists
#1120Polypeptide and use thereof
#1121Peptide with anti-obesity and anti-diabetes activity and use thereof
#1122Peptide with anti-obesity and anti-diabetes activity and use thereof
#1123Peptide with anti-obesity and anti-diabetes activity and use thereof
#1124Peptides derived from the propeptide NTSR3 and their use in the treatment of depression
#1125ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#1126Method for lowering triglyceride
#1127PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING FEMALE SEXUAL DYSFUNCTIONS
#1128Polypeptide and use thereof
#1129Agonists of guanylate cyclase and their uses
#1130Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1131Formulations containing a somatostatin receptor agonist
#1132Compositions and methods for invasive and non-invasive procedural skincare
#1133Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications
#1134Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1135GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#1136USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
#1137Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1138Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1139Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#1140Enhancement of CD47 blockade therapy by proteasome inhibitors
#1141METHODS FOR REDUCING CD36 EXPRESSION
#1142Alpha-v beta-6 integrin ligands and uses thereof
#1143Composition comprising self-assembling peptides for use in treatment of gingivitis, periodontitis and/or peri-implantitis
#1144Anti-B7-H4 antibodies and immunoconjugates
#1145METHODS OF ADMINISTERING HEPCIDIN
#1146Nutritional supplements containing a peptide component and uses thereof
#1147Nanocage
#1148Polymeric nanoparticles useful in theranostics
#1149Method of synthesizing antagonist peptides for cell growth
#1150Opioid agonist peptides and uses thereof
#1151REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#1152METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS
#1153PHARMACEUTICAL ASSOCIATION COMPRISING A GROWTH FACTOR RECEPTOR AGONIST CONJUGATED TO A BIOACTIVE CARRIER FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#1154Nutritional supplements containing a peptide component and uses thereof
#1155Inhibiting tumor cell migration by inhibition of kinesin light chain 1, variant 1 (KLC1C)
#1156Manufacture of Degarelix
#1157PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#1158Methods and kits for assessing Heparanase procoagulant activity, compositions comprising Heparanase, and methods for the treatment of coagulation-related disorders
#1159Methods of treating mild brain injury
#1160BIOMARKERS FOR USE IN DETERMINING RESPONSE TO TREATMENT OF NEURODEGENERATION DISEASE
#1161Cyclic peptide analogs and conjugates thereof
#1162Plectin-1 Targeted Agents for Detection and Treatment of Pancreatic Ductal Adenocarcinoma
#1163PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#1164Low-burst polymers and methods to produce polymer
#1165USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME
#1166Peptide having anticancer activity, and pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and treating cancer comprising the same as active ingredient
#1167Synthetic compound
#1168Compositions and methods for the treatment of neurodamage
#1169Peptides and compositions comprising same and uses thereof in the treatment of diseases
#1170Composition for preventing or treating hyperoxia-induced lung injury comprising WKYMVm peptide as an active ingredient
#1171NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#1172AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#1173METHODS FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY EXTRACELLULAR MICROORGANISMS, INCLUDING ANTIMICROBIAL-RESISTANT STRAINS THEREOF, USING GALLIUM COMPOUNDS
#1174Cancer therapy
#1175INHIBITION OF BIOFILM ORGANISMS
#1176TLR9 TARGETED CYTOTOXIC AGENTS
#1177ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
#1178METHODS FOR TREATING METASTATIC STAGE PROSTATE CANCER
#1179PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF SOMATOSTATIN ANALOGS
#1180Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
#1181Method for treating Alzheimer's disease and method for downregulating protein aggregation in brain
#1182Dosing regimens for echinocandin class compounds
#1183Method of treating cancer cells
#1184Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#1185Toxic RNA inhibitors self-assembled in situ
#1186Antibodies, uses thereof and conjugates thereof
#1187Compounds and pharmaceutical use thereof in the treatment of cancer
#1188Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment
#1189Method and pharmaceutical composition for use in the treatment of cancer
#1190Compositions and methods for treating diseases by inhibiting exosome release
#1191CAR PEPTIDE FOR HOMING, DIAGNOSIS & TARGETED THERAPY FOR PULMONARY AND FIBROTIC DISORDERS
#1192Antibacterial compositions, methods of making and use thereof
#1193Methods comprising desmopressin
#1194Methods for treating autism spectrum disorder and associated symptoms
#1195Therapeutic peptides for excitatory neurotoxicity-related injuries
#1196PREPARATION METHOD OF SUSTAINED-RELEASE MICROPARTICLES
#1197Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a person with pain
#1198NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#1199Peptides and combination of peptides for use in immunotherapy against various tumors
#1200Peptide showing melanin generation-promoting activity and use thereof